Consolidated Condensed Statements of Cash Flows - USD ($) $ in Millions	6 Months Ended
	Jun. 27, 2025	Jun. 28, 2024
Cash flows from operating activities:
Net earnings	$ 1,509	$ 1,995
Noncash items:
Depreciation	366	357
Amortization of intangible assets	836	809
Amortization of acquisition-related inventory fair value step-up	0	25
Stock-based compensation expense	152	147
Investment losses and pretax gain on sale of product line	125	96
Impairment charges	447	0
Change in trade accounts receivable, net	134	590
Change in inventories	(248)	(152)
Change in trade accounts payable	(111)	(104)
Change in prepaid expenses and other assets	(99)	215
Change in accrued expenses and other liabilities	(474)	(822)
Net cash provided by operating activities	2,637	3,156
Cash flows from investing activities:
Cash paid for acquisitions	0	(12)
Payments for additions to property, plant and equipment	(493)	(578)
Proceeds from sales of property, plant and equipment	10	1
Payments for purchases of investments	(50)	(127)
Proceeds from sales of investments	10	9
Proceeds from sale of product line	9	0
All other investing activities	14	26
Total cash used in investing activities	(500)	(681)
Cash flows from financing activities:
Proceeds from the issuance of common stock in connection with stock-based compensation, net	14	76
Payment of dividends	(423)	(377)
Net borrowings (maturities longer than 90 days)	4	0
Net (repayments of) proceeds from borrowings (maturities of 90 days or less)	(1)	15
Net repayments of borrowings (maturities longer than 90 days)	0	(974)
Payments for repurchase of common stock	(1,078)	(4,530)
All other financing activities	(18)	(58)
Total cash used in financing activities	(1,502)	(5,848)
Effect of exchange rate changes on cash and equivalents	244	(117)
Net change in cash and equivalents	879	(3,490)
Beginning balance of cash and equivalents	2,078	5,864
Ending balance of cash and equivalents	2,957	2,374
Supplemental disclosures:
Cash interest payments	149	176
Cash income tax payments	$ 531	$ 618